Omar Abulnaja Kkalid, Ahmed Kherd Ali, Helmi Nawal Mohammed, Abdullah Kumosani Taha, Qarii Mohamad H, Hasan Huwait Etimad, Ashwag Albukhari, Nabil Alaama Mohammed, Abdu Al-Ghamdi Maryam, Salama Moselhy Said
Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Experimental Biochemistry unit, King Fahad Medical Research center (KFMRC), Jeddah, Kingdom of Saudi Arabia.
Afr Health Sci. 2017 Mar;17(1):262-269. doi: 10.4314/ahs.v17i1.32.
Blood-related hereditary diseases are widespread in Eastern and SouthWestern regions of Saudi Arabia until recently. In this study, we used Na, KATPase as an enzymatic indicator for the diagnosis of the diseases.
Individuals with different blood diseases (iron deficiency (n=13), anemia (n=14), thalassemia (n=16) and sickle cell anemia (n=12) were studied for Na, K-ATPase activity in the plasma membrane of red blood cell and compared with those of the healthy ones (n=20) of the same age and gender living in Jeddah, Saudi Arabia.
There was a significant elevation in the specific activity of Na, KATPase in individuals with anemia compared with those of control (0.0094 + 0.001 nmol / mg protein/min versus 0.0061 ± 0.001). On the other hand, there was a significant reduction in enzyme activity in thalassemia (0.0028 ± 0.002 nmol / mg protein/min) and sickle cell anemia cases (0.0042 ±0.001 nmol / mg protein/min) compared to the control group. The cut off value for Na, KATPase activity is 0.005 µmol Pi/min-showing 94% sensitivity and 93% specificity for the differentiation of blood abnormality.
It can be recommended that the activity of Na, K-ATPase can be used for the diagnosis of individuals with blood diseases/disorders.
直到最近,与血液相关的遗传性疾病在沙特阿拉伯的东部和西南部地区仍很普遍。在本研究中,我们使用钠钾ATP酶作为诊断这些疾病的酶指标。
研究了患有不同血液疾病(缺铁性贫血(n = 13)、贫血(n = 14)、地中海贫血(n = 16)和镰状细胞贫血(n = 12))的个体红细胞质膜中的钠钾ATP酶活性,并与生活在沙特阿拉伯吉达的相同年龄和性别的健康个体(n = 20)进行比较。
与对照组相比,贫血个体的钠钾ATP酶比活性显著升高(0.0094 + 0.001纳摩尔/毫克蛋白质/分钟,而对照组为0.0061 ± 0.001)。另一方面,与对照组相比,地中海贫血(0.0028 ± 0.002纳摩尔/毫克蛋白质/分钟)和镰状细胞贫血病例(0.0042 ± 0.001纳摩尔/毫克蛋白质/分钟)的酶活性显著降低。钠钾ATP酶活性的临界值为0.005微摩尔无机磷/分钟,对血液异常的鉴别显示出94%的敏感性和93%的特异性。
可以推荐将钠钾ATP酶的活性用于诊断患有血液疾病/紊乱的个体。